Table 2 |
||
|
Conventional Treatment |
||
|
HOMEOPATHY N (%) |
CONVENTIONAL CARE N(%) |
|
|
|
||
|
Therapies t0-t1 |
||
|
Surgery |
11 (4,3%) |
14 (3,7%) |
|
Chemotherapy |
53 (20,5%) |
244 (64,2%) |
|
Radiation |
21 (8,1%) |
38 (10,0%) |
|
Hormone therapy |
34 (13,2%) |
48 (12,6%) |
|
Other therapies (kinase inhibitors, etc.) |
25 (9,7%) |
52 (13,7%) |
|
Therapies t1-t4 |
||
|
Surgery |
14 (5,4%) |
19 (5,0%) |
|
Chemotherapy 1st line |
56 (21,7%) |
199 (52,4%) |
|
Chemotherapy 2nd line |
20 (7,8%) |
64 (16,8%) |
|
Chemotherapy 3rd line |
10 (3,9%) |
26 (6,8%) |
|
Chemotherapy 4th line |
5 (1,9%) |
3 (0,8%) |
|
Radiation |
22 (8,5%) |
57 (15,0%) |
|
Hormone therapy |
40 (15,5%) |
71 (18,7%) |
|
Other therapies (kinase inhibitors, etc.) |
31 (12%) |
44 (11,5%) |
|
|
||
|
Rostock et al. BMC Cancer 2011 11:19 doi:10.1186/1471-2407-11-19 |
||
